Personal tools
You are here: Home
News
Genzyme rejects Sanofi-Aventis offer

01 Sep, 2010

Biotechnology company Genzyme said it rejected Sanofi-Aventis SA's $18.5 billion buyout offer because it undervalues the company.

Life Sciences Capitals renamed ‘Dutch Life Sciences & Health Conference’

31 Aug, 2010

As from 2010 the Life Sciences Capitals congress will be known as the Dutch Life Sciences & Health Conference. The first conference under the new name will be held on December 8 and is sponsored by the Amsterdam BioMed Cluster en Life Sciences Center.

Call for nominations first BioFarmind Innovation Award

31 Aug, 2010

AMT reports results for the first half year

31 Aug, 2010

Hiv virus arms itself against antibodies

30 Aug, 2010

More news…
Events
BioBusiness Summer School 2010
23 Aug, 2010
Academic Medical Center, Amsterdam,
ESBES - ISPPP - Biothermodynamics 2010
06 Sep, 2010
Bologna, Italy,
IBS 2010 - 14th International Biotechnology Symposium
14 Sep, 2010
Rimini, Italy,
Upcoming events…

 

Know-who Know-how

• By type of organisation…
• By field of application…
• From A to Z…

Our Know-who Know-how Directory of life sciences organisations contains (company) profiles organised by type of organisation and field of application. These individual profiles should serve as a useful source in fostering the establishment of new contacts and collaborations in the industry.

Column

clmn_image

It’s business stupid

What is it with the Dutch that they have such difficulty grabbing business opportunities in a changing world? We have the brains, we have the money and the opportunities are plenty. Still, during the last 40 years hardly any company of substantial size has emerged next to the old industry in the AEX.  Oil, food, materials and financial services dominate the landscape.

We have left the environmental challenges to environmentalists, rather then building innovative businesses in solar or wind energy to help face them. We have exported our knowledge on agriculture around the world, and now that we can more intelligently engineer crops we let the opportunity pass due to invalid arguments around GMOs. Now that  “kweekersrecht” is being substituted by patent law we complain instead of adapt.

Continue

 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: